Amundi’s Covetrus, Inc. Common Stock CVET Stock Holding History

Amundi’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-30,315	Closed	-$550K	–	1733
2021 Q3	$550K	Buy	+30,315	New	+$695K	﹤0.01%	1347

Other funds holding CVET

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FCM

Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return

Amundi's CVET Position: Q4 2021 in Review

Amundi sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2021, closing a stake of 30,315 shares — an estimated $550K sold.

Amundi first reported a position in CVET in Q3 2021 and held it in 1 quarter. The position peaked at $550K in Q3 2021. 246 funds tracked by Wall St. Rank hold CVET as of Q4 2021.

Amundi reported no remaining Covetrus, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Amundi sold 30,315 Covetrus, Inc. Common Stock shares in Q4 2021, an estimated $550K.
Amundi first reported a position in Covetrus, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
Amundi's Covetrus, Inc. Common Stock position peaked at $550K in Q3 2021.
246 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2021.

Based on Amundi's 13F filing for Q4 2021, filed 14 Feb 2022.